Monoclonal Antibodies

1 article

A glowing vial of experimental Ebola therapy in a sterile lab, with a medical professional in the background, representing a critical public health response.

HHS Authorizes Experimental Ebola Therapy for High-Risk Exposures

The U.S. Department of Health and Human Services (HHS) has authorized an experimental monoclonal antibody treatment, MBP-134, for Americans facing high-risk Ebola exposures. This move sidesteps tradit

Marcus Cole·June 5, 2026